An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers

CompletedOBSERVATIONAL
Enrollment

247

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
StrokePrevention and ControlAtrial Fibrillation
Interventions
DRUG

Direct Oral Anticoagulant (DOAC)

Treatment pattern following the summary of product characteristics

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY